Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.9M
-
Number of holders
-
169
-
Total shares
-
52.1M
-
Shares change
-
-987K
-
Total reported value, excl. options
-
$1.68B
-
Value change
-
-$42.4M
-
Number of buys
-
93
-
Number of sells
-
-85
-
Price
-
$32.32
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q3 2015
169 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q3 2015.
HAEMONETICS CORP - Common Stock (HAE) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.1M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3.77M shares), Neuberger Berman Group LLC (3.72M shares), BlackRock Fund Advisors (3.06M shares), WELLS FARGO & COMPANY/MN (2.44M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (2.24M shares), Black Creek Investment Management Inc. (2.04M shares), FMR LLC (1.93M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.85M shares), WESTWOOD HOLDINGS GROUP INC (1.85M shares), and WELLINGTON MANAGEMENT GROUP LLP (1.49M shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.